Publications by authors named "Lisa Moorehead"

Claim this Profile
P
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Erik Mogalian, Diana M Brainard, Anu Osinusi, Lisa Moorehead, Bernard Murray

Clin Pharmacokinet· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development.
Jim Zheng, Yan Xin, Jingyu Zhang, Raju Subramanian, Bernard P Murray, Lisa Moorehead

Drug Metab Dispos· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.
Erik Mogalian, Polina German, Brian P Kearney, Cheng Yong Yang, Diana Brainard, Lisa Moorehead

Clin Pharmacokinet· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients.
Eric J Lawitz, John M Hill, Thomas Marbury, Michael P Demicco, William Delaney, Lisa Moorehead

Antivir Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonist.
Uri Lopatin, Grushenka Wolfgang, Daniel Tumas, Christian R Frey, Carol Ohmstede, Lisa Moorehead

Antivir Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C.
Eric J Lawitz, Daniel Gruener, John M Hill, Thomas Marbury, Lisa Moorehead

J Hepatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection.
Bruce C Trapnell, Susanna A McColley, Dana G Kissner, Mark W Rolfe, Jonathan M Rosen, Lisa Moorehead

Am J Respir Crit Care Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis